Oral glutathiones effects may be slower or inconsistent, while IV glutathione works immediately but requires a clinical setting
Treatments vary, depending on the cause, but anti-inflammatory medications, pain relievers, and in serious cases, immunosuppressant drugs may be necessary
Compounded GLP-1 options from licensed 503A pharmacies offer an alternative pathway to branded medications, allowing for personalized dosing and flexibility
Diarrhea affected 13-16% of patients with diabetes and up to 30% in obesity trials, while vomiting occurred in 5-9% of those treated with tirzepatide for diabetes and up to 24% in obesity studies
SURMOUNT-1 (Obesity without T2D) The SURMOUNT-1 trial was a landmark study that enrolled 2,539 participants with obesity or overweight (but without T2D) and at least one weight-related comorbidity